News | September 28, 2011

ISET 2012 Explores the Future of Endovascular Therapy

September 28, 2011 — The 24th annual International Symposium on Endovascular Therapy (ISET) will take place Jan. 15-19, 2012, at the Fontainebleau Miami Beach. More than 1,500 members of the global endovascular community will be in attendance; this includes physicians, researchers, scientists, biomedical engineers, nurses, technologists and other industry professionals. The fields of interventional radiology, interventional cardiology and vascular surgery will be represented, among others.

ISET attendees will experience:

· Four days of concentrated symposia, general and concurrent sessions and small-group case review sessions led by experts in interventional radiology, interventional cardiology and vascular surgery

· The latest research from internationally renowned experts including first-time and updated clinical trial results

· Peripheral and coronary live cases featuring devices in use in the United States and abroad

· Interactive polling to survey attendees’ thoughts and opinions in real time

· A new program, “ISET Master Class,” which will provide a limited number of attendees the opportunity to thoroughly discuss and analyze a complicated case presentation from all angles – from the medical course of action to business and financial concepts to social, regulatory and reimbursement challenges.

In collaboration with ISET 2012, the Symposium on Clinical Interventional Oncology, North America’s largest interventional oncology meeting, will take place Jan. 14-15.

For more information: www.iset.org

 

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Overlay Init